Medication info

Hyriem Tablet 10/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin Micronized›10mg / 1 tabletLinagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
Flat on both sides and a thin triangular film-coated tablet with sharp edges that is pale yellow
Packaging
Bottle - 30 tablets/bottle, PTP - 30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202402465 · Approved 2024.10.21

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant therapy with empagliflozin and linagliptin should receive their existing doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of your next dose, skip the missed dose and take your next dose at the usual time. Do not take a double dose in one day. Patients with renal impairment: This medicine is not recommended for improving glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is required in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults: No dose adjustment based on age is required. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It is particularly effective as an adjunct to dietary and exercise therapy when combined use of empagliflozin and linagliptin is appropriate. It helps manage blood sugar levels stably to assist in diabetes treatment.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant therapy with empagliflozin and linagliptin should receive their existing doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of your next dose, skip the missed dose and take your next dose at the usual time. Do not take a double dose in one day. Patients with renal impairment: This medicine is not recommended for improving glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is required in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults: No dose adjustment based on age is required. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication contains empagliflozin and linagliptin, and is used for diabetes treatment. First, this medication should not be used in patients who are allergic to empagliflozin, linagliptin, or other components of this medication, in patients with type 1 diabetes, diabetic ketoacidosis, or patients undergoing dialysis. Patients with impaired kidney function may experience reduced effectiveness of this medication, so regular kidney function tests should be conducted before and during treatment, and caution is needed if taking other medications that may affect kidney function. Careful use is required for patients with mild to moderate heart failure (New York Heart Association Functional Classification I-II), while it is not recommended for patients with severe heart failure (Classification III-IV). This medication carries a risk of pancreatitis; if severe abdominal pain persists, consult a doctor immediately and consider discontinuing use. Additionally, there may be a risk of blistering similar to bullous pemphigoid; notify medical personnel immediately if any skin abnormalities occur. The most common side effect is urinary tract infection; in addition, hypoglycemia, thirst, cough, constipation, itching, rash, and increased urination have also been reported. Particularly when taken with medications that pose a risk of hypoglycemia, such as insulin or sulfonylureas, the risk of hypoglycemia increases, so blood sugar levels should be monitored closely. This medication can cause hypotension or dehydration due to fluid loss, so special caution is required for elderly patients or those with low blood pressure, and treatment may be temporarily suspended in cases of dehydration. Moreover, this medication may increase the risk of genital fungal infections, and appropriate treatment may be necessary if relevant symptoms develop. It is advisable not to use this medication during pregnancy unless under special circumstances, and discontinuation of breastfeeding is recommended if nursing. The safety and efficacy in children under 18 years have not been established, so it should not be used in this age group. In case of overdose, appropriate medical treatment should be sought immediately, and this medication should be kept out of the reach of children. During treatment, caution should be exercised when driving or operating machinery due to the risk of hypoglycemia, especially when taken with other hypoglycemia-inducing medications. Finally, diabetic patients should pay attention to foot care as usual, and if they experience pain or swelling around the perineum while taking this medication, they should inform medical personnel immediately and seek treatment.

Side effects

  • Urinary tract infection
  • pyelonephritis
  • urosepsis
  • vulvovaginitis
  • balanitis
  • other genital infections
  • hypersensitivity reactions
  • angioedema
  • hives
  • hypoglycemia
Show 197 more
  • thirst
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcers
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • decreased fluid volume
  • increased urination
  • difficulty urinating
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • elevated serum creatinine
  • decreased glomerular filtration rate
  • constipation
  • upper abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • stuttering
  • Alzheimer's type dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot disease
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • colorectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • abdominal pain
  • gastrointestinal disorders
  • irritable bowel syndrome
  • burning mouth syndrome
  • colitis
  • abdominal discomfort
  • dysphagia
  • gastric ulcer
  • gum bleeding
  • tooth loss
  • hemorrhoids
  • lower abdominal pain
  • diarrhea
  • vomiting
  • gastritis
  • acute pyelonephritis
  • leukoplakia
  • rhinitis
  • soft tissue infection
  • pharyngitis
  • scrub typhus
  • periodontitis
  • tonsillitis
  • laryngitis
  • viral upper respiratory infection
  • tonsillitis
  • decreased appetite
  • hypercholesterolemia
  • inadequate control of diabetes
  • malnutrition
  • hyponatremia
  • headache
  • drowsiness
  • asthenia
  • chest discomfort
  • nosebleed
  • oropharyngeal pain
  • voice disorders
  • allergic rhinitis
  • exertional dyspnea
  • wet cough
  • runny nose
  • pulmonary mass
  • arthralgia
  • osteoporosis
  • arthropathy
  • musculoskeletal discomfort
  • myositis
  • myalgia
  • soft tissue mass
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • increased serum triglycerides
  • increased urine albumin/creatinine ratio
  • positive urine leukocytes
  • decreased hemoglobin
  • increased serum potassium
  • increased serum creatinine
  • increased serum creatine kinase activity
  • increased ALT
  • male-pattern baldness
  • hyperhidrosis
  • hair loss
  • dermatitis
  • anxiety
  • affective disorder
  • insomnia
  • depression
  • contusion
  • bone contusion
  • concussion
  • bone fracture
  • hand fracture
  • laceration
  • palpitations
  • atherosclerosis
  • deep vein thrombosis
  • peripheral arterial occlusive disease
  • goiter
  • hypothyroidism
  • thyroid nodule
  • earache
  • positional vertigo
  • lymphadenopathy
  • anemia
  • vulvar itching
  • genital itching
  • obesity
  • hyponatremia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • astigmatism
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular congestion
  • pathological myopia
  • retinal detachment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • age-related dyspnea
  • productive cough
  • residual sputum
  • skin laceration
  • rib fracture
  • celiac disease
  • dry eye
  • cataract
  • ocular discomfort
  • allergic conjunctivitis
  • benign prostatic hyperplasia
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervicitis
  • vaginal discharge

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius. This helps maintain the effectiveness of the medication and ensures safe use.

Appearance and packaging

Appearance

Flat on both sides and a thin triangular film-coated tablet with sharp edges that is pale yellow

Package unit

Bottle - 30 tablets/bottle, PTP - 30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.